Member of the Order of Canada

• Awarded on: May 13, 2004
• Invested on: June 10, 2005

Robert Young has provided exceptional leadership in pharmaceutical and biomedical research in Canada. Vice-president of medicinal chemistry at the Merck Frosst Centre for Therapeutic Research, he was instrumental in leading his team in the discovery and commercialization of new medications for allergies and inflammatory diseases, such as asthma and arthritis. These advancements have greatly improved the quality of life for many Canadians. Throughout his career, he has also been actively involved in many advisory committees of national and international scientific organizations.